Market Analysis and Insights: Global Thoracic Stent-Graft and Delivery System Market
Due to the COVID-19 pandemic, the global Thoracic Stent-Graft and Delivery System market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, 24-34mm accounting for % of the Thoracic Stent-Graft and Delivery System global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Thoracic Stent-Graft and Delivery System market size is valued at US$ million in 2021, while the US and Europe Thoracic Stent-Graft and Delivery System are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Thoracic Stent-Graft and Delivery System landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Thoracic Stent-Graft and Delivery System include Medtronic, JOTEC GmbH, SB-Kawasumi Laboratories, Terumo Aortic, VuMedi, W. L. Gore & Associates, Shanghai MicroPort Endovascular and LifeTech Scientific, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Thoracic Stent-Graft and Delivery System Scope and Segment
Thoracic Stent-Graft and Delivery System market is segmented by Graft Diameter and by Application. Players, stakeholders, and other participants in the global Thoracic Stent-Graft and Delivery System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Graft Diameter and by Application for the period 2017-2028.
Segment by Graft Diameter
24-34mm
36-44mm
Others
Segment by Application
Hospitals
Clinics
By Company
Medtronic
JOTEC GmbH
SB-Kawasumi Laboratories
Terumo Aortic
VuMedi
W. L. Gore & Associates
Shanghai MicroPort Endovascular
LifeTech Scientific
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE